Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History $4.38 +0.28 (+6.69%) As of 02:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics Stock Price Performance 5 Day Performance+6.95%1 Month Performance-8.65%3 Month Performance-26.55%6 Month Performance-70.25%Year-To-Date Performance-44.00%1 Year Performance-74.58% Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address YMAB Stock Chart for Friday, May, 2, 2025 YMAB Chart by TradingView Y-mAbs Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$4.25$4.11-3.29%$4.29$4.02203,869 shs$185.85 million04/30/2025$4.20$4.25+1.19%$4.33$4.10169,597 shs$192.18 million04/29/2025$4.23$4.20-0.71%$4.34$4.10152,403 shs$189.92 million04/28/2025$4.10$4.23+3.17%$4.27$4.08120,647 shs$191.27 million04/25/2025$4.13$4.10-0.73%$4.12$3.94108,610 shs$185.39 million04/24/2025$4.12$4.13+0.24%$4.14$3.91216,544 shs$186.75 million04/23/2025$4.26$4.12-3.29%$4.40$4.11181,491 shs$186.30 million04/22/2025$4.82$4.26-11.62%$4.61$3.84563,438 shs$192.63 million04/21/2025$4.69$4.82+2.77%$4.93$4.59143,300 shs$217.95 million04/18/2025$4.69$4.69$4.73$4.51107,040 shs$212.07 million Get the Latest News and Ratings for YMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$4.54$4.69+3.30%$4.73$4.51107,040 shs$212.07 million04/16/2025$5.35$4.54-15.14%$5.29$4.46261,506 shs$205.29 million04/15/2025$4.93$5.35+8.52%$5.44$4.93273,605 shs$241.92 million04/14/2025$4.83$4.93+2.07%$5.01$4.68185,021 shs$222.93 million04/11/2025$4.35$4.83+11.03%$4.88$4.40217,133 shs$218.40 million04/10/2025$4.45$4.35-2.25%$4.45$4.18182,226 shs$196.70 million04/09/2025$4.09$4.45+8.80%$4.67$3.86248,915 shs$201.22 million04/09/2025$4.09$4.45+8.80%$4.67$3.86248,915 shs$201.22 million04/08/2025$4.28$4.09-4.44%$4.50$4.03235,473 shs$184.94 million04/08/2025$4.28$4.09-4.44%$4.50$4.03235,473 shs$184.94 million04/07/2025$4.54$4.28-5.73%$4.67$4.13487,559 shs$193.53 million04/04/2025$4.66$4.54-2.58%$4.64$4.30279,388 shs$205.29 million04/03/2025$4.80$4.66-2.92%$4.74$4.33822,651 shs$210.72 million04/02/2025$4.50$4.80+6.67%$4.82$4.40238,826 shs$217.05 million04/01/2025$4.43$4.50+1.58%$4.52$4.25261,572 shs$203.48 million Related Companies RCKT Stock Chart QURE Stock Chart XNCR Stock Chart LENZ Stock Chart PAHC Stock Chart IMNM Stock Chart PRAX Stock Chart NUVB Stock Chart EOLS Stock Chart REPL Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
